Head and Neck Cancers | 2011/06/01 | | 127 |
NCCN Task Force Report: Management of Neuropathy in Cancer | 2009/09/01 | | 127 |
Cancer- and Chemotherapy-Induced Anemia | 2012/05/01 | English | 127 |
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology | 2020/12/01 | | 125 |
Breast Cancer, Version 3.2018 | 2019/02/01 | | 125 |
Myelodysplastic Syndromes | 2011/01/01 | | 125 |
Distress Management | 2010/04/01 | | 123 |
Implementation of NCCN Distress Management Guidelines by Member Institutions | 2007/01/01 | | 123 |
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology | 2022/04/01 | | 123 |
NCCN Guidelines Insights: Antiemesis, Version 2.2017 | 2017/07/01 | English | 123 |
The 2010 NCCN Clinical Practice Guidelines in Oncology on Prostate Cancer | 2010/02/01 | | 121 |
Neuroendocrine Prostate Cancer: Subtypes, Biology, and Clinical Outcomes | 2014/05/01 | English | 121 |
Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era | 2017/07/01 | English | 121 |
Pancreatic Adenocarcinoma | 2010/09/01 | | 120 |
NCCN Task Force Report: Bone Health in Cancer Care | 2009/06/01 | | 119 |
Breast Cancer Version 2.2015 | 2015/04/01 | English | 118 |
Penile Cancer | 2013/05/01 | English | 118 |
Adult Cancer Pain | 2013/08/01 | English | 118 |
Prevention and Treatment of Cancer-Related Infections | 2012/11/01 | English | 117 |
Non–Small Cell Lung Cancer, Version 1.2015 | 2014/12/01 | English | 117 |
Non-Small Cell Lung Cancer Guidelines | 2006/07/01 | | 114 |
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology | 2022/08/01 | | 114 |
Acute Myeloid Leukemia, Version 2.2013 | 2013/09/01 | English | 113 |
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015 | 2016/02/01 | English | 112 |
Gastric Cancer | 2010/04/01 | | 111 |
Breast Cancer, Version 3.2013 | 2013/07/01 | English | 110 |
Mucosal Melanoma: A Clinically and Biologically Unique Disease Entity | 2012/03/01 | English | 109 |
Head and Neck Cancers, Version 2.2013 | 2013/08/01 | English | 108 |
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022 | 2022/09/01 | | 107 |
Adult Cancer Pain | 2010/09/01 | English | 106 |